Stay Ahead of the Science
Access the latest peer-reviewed research on microRNA (miRNA) biomarkers, AI-driven analysis, and their role in early cancer detection.
Over the past decade, research in cancer biology has revealed the critical role of microRNAs (miRNAs) — small RNA molecules that regulate gene activity and change when cancer begins to develop.
Studies Show That:
- microRNA patterns reflect early cellular changes in common solid tumours such as lung, breast, colorectal, prostate, and pancreatic cancers.
- AI analysis improves accuracy by identifying subtle molecular signals across large human datasets.
- Validation on 11,000+ samples achieved over 99% specificity, with results published in Cancers and Scientific Reports.
This science forms the foundation of miRoncol’s Real-time Multi-Cancer Early Risk Assessment — a blood-based pre-screening tool that complements physician-led preventive care.
